BEAM 19.87 (+3.87%)
US07373V1052BiotechnologyBiotechnology

Beam Therapeutics (BEAM) Stock Highlights

19.87 | +3.87%
2025-04-24 04:21:43
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The companys portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.

Statistics

Range Today
19.85 20.81
Volume Today 2.13M
Range 1 Year
13.52 35.25
Volume 1 Year 345.57M
Range 3 Year
13.52 73.27
Volume 3 Year 908.81M
Range 10 Year
13 138.52
Volume 10 Year 1.32B

Highlights

Market Capitalization 1.7B (small)
Floating Shares 73.2M
Current Price 19.87
Price To Earnings -3.62
Price To Revenue 10.86
Price To Book 1.88
Earnings Per Share -4.58
Payout Ratio 0%

Performance

Latest +3.87%
1 Month -16.27%
3 Months -23.78%
6 Months -12.2%
1 Year -17.35%
3 Years -52.69%
5 Years +18.2%
10 Years -17.21%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.